Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05900024 · ClinicalTrials.gov registry record · NA
A Study to Evaluate the Effect of Funk It Cycle Bites on PMS
A NA study of Premenstrual Syndrome, sponsored by Funk It Wellness.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT05900024: Completed NA study of Premenstrual Syndrome, sponsored by Funk It Wellness.
NCT05900024 is a NA study of Premenstrual Syndrome that has completed, run by Funk It Wellness. The registered enrollment target is 30 participants, below the 130-participant average among 6 other Premenstrual Syndrome trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05900024, a NA study of Premenstrual Syndrome, has completed, sponsored by Funk It Wellness.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a virtual, open-label, single-group study that will last 4 menstrual cycles. All participants will complete a questionnaire at the end of their first period after enrolling (baseline/non-intervention cycle 1), then proceed to take the product daily and complete questionnaires at the end of their next 3 periods (intervention cycles 1, 2, and 3). The study will involve 30 female participants with regular menstrual cycles who experience PMS. Questionnaires will be used to monitor menstrual pain/cramps, energy levels, mood, and hormonal acne experienced before and during the menstrual cycle. Likert scale responses will be statistically compared from baseline to each check-in. Participant responses on product feedback will be presented as % scores.
Primary Outcome
Survey-based assessment of symptoms using the Premenstrual Symptoms Screening Tool (PSST). Responses will be gathered using a 4-point Likert scale.
Conditions Studied
Interventions
- OTHER Funk It Cycle Bites
Study Locations (1)
California
- Citruslabs - Santa Monica
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-05-01 |
| Est. Completion | 2023-10-01 |
| Phase | NA |
What the finished NCT05900024 record still lists
NCT05900024 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 130-participant average among 6 other Premenstrual Syndrome trials with a reported enrollment target (77% lower).
The record links to 1 condition, with Premenstrual Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Funk It Cycle Bites is the first listed.
NCT05900024 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05900024 about?
NCT05900024 is a clinical study titled "A Study to Evaluate the Effect of Funk It Cycle Bites on PMS". This is a virtual, open-label, single-group study that will last 4 menstrual cycles. All participants will complete a questionnaire at the end of their first period after enrolling (baseline/non-intervention cycle 1), then proceed to take the product daily and complete questionnaires at the end of t...
What is the current status of trial NCT05900024?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2023-05-01. Estimated completion is 2023-10-01.
What conditions does trial NCT05900024 study?
This clinical trial studies the following conditions: Premenstrual Syndrome.
What interventions are being tested in trial NCT05900024?
The interventions under investigation include: Funk It Cycle Bites (OTHER).
Who is sponsoring clinical trial NCT05900024?
This trial is sponsored by Funk It Wellness, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05900024 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Premenstrual Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Moderate Aerobic Exercise for Managing Menstrual Cycle Symptoms
RECRUITING · NA
-
Effects of a Female Hormone Balance Supplement on Symptoms of Polycystic Ovary Syndrome and Severe Premenstrual Syndrome
COMPLETED · NA
-
Effects of a Female Hormone Balance Supplement on Premenstrual Syndrome Symptoms
COMPLETED · NA
-
Identification and Validation of Epigenetic Biomarkers of PMDD
RECRUITING
-
Antidepressant Treatment for Premenstrual Syndrome and Premenstrual Dysphoric Disorder
COMPLETED · Phase 1
-
An Investigation Into the Efficacy of a Botanical Supplement to Provide Period Relief
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI